Thrombolytic Care During Inter-hospital Transfer
Status
Conditions
Treatments
Details and patient eligibility
About
Evaluation of ischemic stroke patients receiving tissue plasminogen activator (rtPA) during air ambulance transfer
Full description
The purpose of our study is to evaluate the effect of air ambulance transport on patients presenting with an ischemic stroke and receive tissue plasminogen activator (rtPA). Primary outcome will be the evaluation of air ambulance transfer and if it leads to protocol violations or significant delays in therapy. Protocol violations include inaccurate dosing or preparation at the outside hospital, uncontrolled blood pressure before and during the flight, unnecessary medication administration before and during the flight and adverse events (intracranial bleeding, allergic reaction) associated with transfer process. Additional evaluation will include the effects of vibration of the air ambulance and its effects on the lytic activity of rtPA. rtPA is not supposed to be significantly agitated after it is prepared in solution and there is significant vibration and agitation during air ambulance transfer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patients who received tissue plasminogen activator for acute ischemic stroke
- presented directly to comprehensive stroke center or were transferred by our air ambulance service
Exclusion criteria
- Transferred by another air ambulance service or ground ambulance
Trial design
76 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal